Prognostic implications of volume-based measurements on FDG PET/CT in stage III non-small-cell lung cancer after induction chemotherapy - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue European Journal of Nuclear Medicine and Molecular Imaging Année : 2013

Prognostic implications of volume-based measurements on FDG PET/CT in stage III non-small-cell lung cancer after induction chemotherapy

Résumé

We sought to determine whether metabolic volume-based measurements on FDG PET/CT scans could provide additional information for predicting outcome in patients with stage III non-small-cell lung cancer (NSCLC) treated with induction chemotherapy.

Dates et versions

hal-02401430 , version 1 (10-12-2019)

Identifiants

Citer

Michaël Soussan, Kader Chouahnia, Jacques-Antoine Maisonobe, Marouane Boubaya, Véronique Eder, et al.. Prognostic implications of volume-based measurements on FDG PET/CT in stage III non-small-cell lung cancer after induction chemotherapy. European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 (5), pp.668-676. ⟨10.1007/s00259-012-2321-7⟩. ⟨hal-02401430⟩
55 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More